83 related articles for article (PubMed ID: 30593761)
41. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
[TBL] [Abstract][Full Text] [Related]
42. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
[TBL] [Abstract][Full Text] [Related]
43. Predictive value of preoperative carcinoembryonic antigen levels for the prognosis of patients with well-differentiated gastric cancer. A multivariate analysis.
Maehara Y; Kusumoto T; Takahashi I; Kakeji Y; Baba H; Akazawa K; Sugimachi K
Oncology; 1994; 51(3):234-7. PubMed ID: 8196905
[TBL] [Abstract][Full Text] [Related]
44. Autoantibodies in the serum of patients with gastric cancer: their prognostic importance.
Konstandoulakis MM; Syrigos KN; Leandros M; Charalabopoulos A; Manouras A; Golematis BC
Hybridoma; 1998 Oct; 17(5):431-5. PubMed ID: 9873988
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of the preoperative serum levels of soluble form of endoglin in gastric cancer patients.
Gomceli I; Tez M; Bostanci EB; Kemik AS; Demiriz B; Akoglu M
Bratisl Lek Listy; 2013; 114(10):566-8. PubMed ID: 24156679
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of circulating plasma DNA in gastric cancer.
Fang WL; Lan YT; Huang KH; Liu CA; Hung YP; Lin CH; Jhang FY; Chang SC; Chen MH; Chao Y; Lin WC; Lo SS; Fen-Yau Li A; Wu CW; Chiou SH; Shyr YM
Int J Cancer; 2016 Jun; 138(12):2974-83. PubMed ID: 26815009
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer.
Dilege E; Mihmanli M; Demir U; Ozer K; Bostanci O; Kaya C; Aksakal O; Sakiz D
Hepatogastroenterology; 2010; 57(99-100):674-7. PubMed ID: 20698248
[TBL] [Abstract][Full Text] [Related]
48. Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients.
Saito H; Kono Y; Murakami Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T
Langenbecks Arch Surg; 2017 May; 402(3):501-507. PubMed ID: 28293741
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
[TBL] [Abstract][Full Text] [Related]
51. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
[TBL] [Abstract][Full Text] [Related]
52. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
[TBL] [Abstract][Full Text] [Related]
53. Relationship between the Body Mass Index and Tumor Site Postoperative Complications and Prognosis in Gastric Adenocarcinoma.
Wang F; Liu X; Mao P; Meng Q; Zhang D; Liu B
Am Surg; 2018 Dec; 84(12):1861-1868. PubMed ID: 30606340
[TBL] [Abstract][Full Text] [Related]
54. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
Tahir SA; Frolov A; Hayes TG; Mims MP; Miles BJ; Lerner SP; Wheeler TM; Ayala G; Thompson TC; Kadmon D
Clin Cancer Res; 2006 Aug; 12(16):4872-5. PubMed ID: 16914574
[TBL] [Abstract][Full Text] [Related]
55. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
Potrc S; Gadiijev E; Hajdinjak T; Kavalar R
Hepatogastroenterology; 2007; 54(73):308-14. PubMed ID: 17419281
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
58. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
[TBL] [Abstract][Full Text] [Related]
59. Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer.
Komatsu S; Ichikawa D; Nishimura Y; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Anticancer Res; 2013 Apr; 33(4):1621-7. PubMed ID: 23564806
[TBL] [Abstract][Full Text] [Related]
60. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
Alici S; Kaya S; Izmirli M; Tuncer I; Doğan E; Ozbek H; Sayarlioglu H
Med Sci Monit; 2006 May; 12(5):CR221-9. PubMed ID: 16641880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
